Dublin, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The "Antisense & RNAi Therapeutics - A Global Market Overview" report has been ...

界面新闻记者 | 黄华界面新闻编辑 | 谢欣10月8日，渤健（Biogen）旗下的托夫生注射液（商品名：凯盛迪）在国内获批，成为中国首个获批用于携带超氧化物歧化酶1（SOD1）基因突变的肌萎缩侧索硬化（ALS）成人患者的疾病修正治疗药物。肌萎缩侧索硬化（Amyotrophic Lateral ...

Trace Neuroscience Launches with $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases, ...

Oblimersen sodium (Genasense™) is an antisense oligodeoxynucleotide specific for the antiapoptotic protein Bcl-2, which could enhance the sensitivity of leukemic cells to chemotherapy in this ...

In a study led by researchers at the NUS Yong Loo Lin School of Medicine, extracellular vesicles loaded with customizable ...

DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...

We have observed substantial anti–tumor activity against a range of tumor types in xenograft models after administration of the C–raf antisense. However, the doses required to achieve anti ...

The sizeable new round follows the announcement of phase 1 data for its lead asset MET-097i in September, and according to ...

Researchers have used microcellular "drones" to deliver antisense oligonucleotide therapeutics to lung cancer cells.

Development in RNA interference (RNAi) and antisense oligonucleotide (ASO) technologies underpins the growth, as they provide ...